Stocktoria
Quantum Cyber N.V. QUCY
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-11-04
Quantum Cyber N.V. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $537,080 | $893,991 |
| Gross profit | $389,792 | $574,883 |
| R&D expense | $4.9M | $5.7M |
| Operating income | -$16.1M | -$18.8M |
| Net income | -$16.2M | -$21.6M |
| EPS (diluted) | $-2.70 | $-21.91 |
| Operating cash flow | -$11.0M | -$17.3M |
| Free cash flow | -$11.0M | -$17.4M |
| Inventory | $216,888 | $372,870 |
| Total assets | $5.3M | $13.5M |
| Total liabilities | $4.7M | $7.5M |
| Shareholders' equity | $641,600 | $6.0M |
Growth · year-over-year · Revenue CAGR -39.9%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | -39.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.